Proficio Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,289
| Closed | -$523K | – | 407 |
|
|
2025
Q2 | $523K | Sell |
1,289
-236
| -15% | -$98.7K | 0.03% | 235 |
|
|
2025
Q1 | $759K | Buy |
1,525
+59
| +4% | +$32K | 0.06% | 155 |
|
|
2024
Q4 | $763K | Buy |
1,466
+356
| +32% | +$196K | 0.06% | 131 |
|
|
2024
Q3 | $687K | Sell |
1,110
-328
| -23% | -$194K | 0.07% | 116 |
|
|
2024
Q2 | $795K | Buy |
1,438
+123
| +9% | +$70.5K | 0.08% | 125 |
|
|
2024
Q1 | $764K | Buy |
1,315
+116
| +10% | +$65.1K | 0.08% | 128 |
|
|
2023
Q4 | $637K | Sell |
1,199
-75
| -6% | -$36.3K | 0.08% | 130 |
|
|
2023
Q3 | $645K | Buy |
1,274
+18
| +1% | +$9.59K | 0.09% | 120 |
|
|
2023
Q2 | $655K | Sell |
1,256
-16
| -1% | -$8.63K | 0.09% | 125 |
|
|
2023
Q1 | $733K | Buy |
1,272
+154
| +14% | +$86.8K | 0.12% | 108 |
|
|
2022
Q4 | $616K | Sell |
1,118
-39
| -3% | -$20.7K | 0.12% | 108 |
|
|
2022
Q3 | $589K | Buy |
1,157
+33
| +3% | +$18.5K | 0.11% | 108 |
|
|
2022
Q2 | $611K | Buy |
1,124
+114
| +11% | +$62.7K | 0.11% | 109 |
|
|
2022
Q1 | $597K | Sell |
1,010
-334
| -25% | -$192K | 0.09% | 119 |
|
|
2021
Q4 | $897K | Sell |
1,344
-35
| -3% | -$21.9K | 0.12% | 99 |
|
|
2021
Q3 | $788K | Buy |
1,379
+28
| +2% | +$15.4K | 0.1% | 110 |
|
|
2021
Q2 | $682K | Buy |
1,351
+45
| +3% | +$21.2K | 0.08% | 115 |
|
|
2021
Q1 | $596K | Buy |
1,306
+79
| +6% | +$37.7K | 0.08% | 116 |
|
|
2020
Q4 | $572K | Sell |
1,227
-13
| -1% | -$6.09K | 0.09% | 91 |
|
|
2020
Q3 | $547K | Buy |
1,240
+49
| +4% | +$20.2K | 0.1% | 87 |
|
|
2020
Q2 | $432K | Buy |
1,191
+113
| +10% | +$37.9K | 0.09% | 96 |
|
|
2020
Q1 | $318K | Buy |
+1,078
| New | +$340K | 0.08% | 106 |
|
|
2019
Q3 | – | Sell |
-669
| Closed | -$196K | – | 1396 |
|
|
2019
Q2 | $196K | Buy |
669
+167
| +33% | +$46K | 0.07% | 127 |
|
|
2019
Q1 | $137K | Buy |
502
+16
| +3% | +$3.98K | 0.05% | 163 |
|
|
2018
Q4 | $109K | Buy |
486
+7
| +1% | +$1.64K | 0.05% | 163 |
|
|
2018
Q3 | $117K | Buy |
479
+7
| +1% | +$1.61K | 0.04% | 184 |
|
|
2018
Q2 | $98K | Sell |
472
-5
| -1% | -$1.06K | 0.04% | 211 |
|
|
2018
Q1 | $98K | Buy |
477
+16
| +3% | +$3.36K | 0.03% | 215 |
|
|
2017
Q4 | $88K | Buy |
461
+17
| +4% | +$3.26K | 0.03% | 231 |
|
|
2017
Q3 | $84K | Sell |
444
-7
| -2% | -$1.27K | 0.03% | 270 |
|
|
2017
Q2 | $80K | Sell |
451
-156
| -26% | -$26.2K | 0.03% | 287 |
|
|
2017
Q1 | $105K | Buy |
607
+253
| +71% | +$38.7K | 0.05% | 242 |
|
|
2016
Q4 | $50K | Sell |
354
-14
| -4% | -$2.06K | 0.02% | 265 |
|
|
2016
Q3 | $59K | Buy |
368
+34
| +10% | +$5.24K | 0.03% | 242 |
|
|
2016
Q2 | $53K | Buy |
334
+2
| +0.6% | +$295 | 0.03% | 258 |
|
|
2016
Q1 | $47K | Buy |
332
+265
| +396% | +$35.5K | 0.04% | 224 |
|
|
2015
Q4 | $10K | Buy |
+67
| New | +$8.94K | 0.01% | 279 |
|
Other funds holding TMO
Proficio Capital Partners's TMO Position: Q3 2025 in Review
Proficio Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 1,289 shares — an estimated $523K sold.
Proficio Capital Partners first reported a position in TMO in Q4 2015 and held it in 37 quarters. The position peaked at $897K in Q4 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Proficio Capital Partners reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
- Proficio Capital Partners sold 1,289 Thermo Fisher Scientific shares in Q3 2025, an estimated $523K.
- Proficio Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2015 and held it in 37 quarters.
- Proficio Capital Partners's Thermo Fisher Scientific position peaked at $897K in Q4 2021.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Proficio Capital Partners's 13F filing for Q3 2025, filed 12 Nov 2025.